COVID-19
In the context of the situation associated with the spread of coronavirus infections in the world and the Russian Federation, FSUE “Moscow Endocrine Plant” informs about the availability of sufficient resources to meet the entire demand of the manufacured products, as well as continue to manufacture the necessary nomenclature of products upon the additional requests.
The Company has established a headquarters and approved a plan of urgent measures to prevent the threat of the spread of a new coronavirus infection. The situation with coronavirus is monitored 24 hours for the purpose of assessing its potential impact on the operation of the Enterprise and ensuring the continuity of production processes and safety of the employees.
There is a set of measures aimed at timely informing the employees on the measures taken by the Russian Government. The Government of the Russian Federation and the Government of Moscow, take all necessary steps in order to prevent the threat of the coronavirus infection spread, as well as to ensure monitoring the health status of employees and the implementation of all preventative measures.
All rooms, door handles, switches, office equipment and other contact surfaces as well as ventilation system at the Company facilities are cleaned every 2 hours with disinfectants means. Additional disinfectants dispensers are installed for the treatment of hands at necessary point in the different areas of the premises. Risk of the mass congestion of the employees at the entrance and exit points are minimized as well as at the general visiting places. The temperature of employees is measured twice a day and when visitors enter the Company's buildings. Persons with respiratory symptoms are not allowed to enter the Enterprise buildings. Limited business trips on the territory. The business trips to the regions of the Russian Federation and foreign trips are cancelled. Meetings and other official mass events have been switched to remote or on-line mode (audio, video format); office employees if necessary will be switched to remote operation mode.
During the period from March 30 till April 3, 2020 production and other activities of the Enterprise are carried out according to the approved plan and volumes.
Reference:
FSUE “Moscow Endocrine Plant” falls under jurisdiction of the Ministry of Industry and Trade of the Russian Federation. It is one of the key producers of vital and socially significant medicines in the country. The Enterprise provides its products to all regions of the Russian Federation.
The product portfolio includes a wide range of medical products for pain management, including palliative care, emergency treatment, hormonal medicines, as well as preparations used in anesthesiology, neurology, psychiatry, ophthalmology, cardiology, gynecology, gastroenterology.